HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) Share Price Near 52-Week Low as Stock Slips 3.43%

HIMALAYA NUTRAVEDICS INDIA LIM Share Price is under fresh attention after the stock traded at Rs 112.65, down 3.43% from the previous close, while staying near its 52-week low and carrying a market capitalisation of Rs 102.73 Cr. The latest Univest market data confirms the price event, but it does not establish a company-specific catalyst. That matters because HIMALAYA NUTRAVEDICS INDIA LIM Share Price Today is now being tracked not just for the one-year low setup, but also for what the current price says about support, valuation and relative positioning in the healthcare space. In Univest stock news coverage, such moves often attract search interest around HIMALAYA NUTRAVEDICS INDIA LIM Share Price, HIMALAYA NUTRAVEDICS INDIA LIM Stock News and HIMALAYA NUTRAVEDICS INDIA LIM Share Price Today.

The stock opened at Rs 112.05, touched a high of Rs 122.45 and a low of Rs 111.05 in the current move. Against the previous close of Rs 116.65, the day change is Rs -4.00. With the share price still close to its yearly low zone, market participants are likely to monitor whether HIMALAYA NUTRAVEDICS INDIA LIM Share Price can stabilise around the recent range or continue to drift. Univest stock analysis tools are useful here because they keep the focus on verified price action, not speculation.

HIMALAYA NUTRAVEDICS INDIA LIM Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 112.65
Previous Close	Rs 116.65
Today's Move	Rs -4 (-3.43%)
Open	Rs 112.05
High	Rs 122.45
Low	Rs 111.05
Market Capitalisation	Rs 102.73 crore

HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) traded at Rs 112.65 versus the previous close of Rs 116.65, a fall of 3.43%. The stock opened at Rs 112.05, reached a high of Rs 122.45, touched a low of Rs 111.05.

HIMALAYA NUTRAVEDICS INDIA LIM Share Price Today shows a weak intraday tone. The stock traded at Rs 112.65 versus the previous close of Rs 116.65, with a day change of Rs -4.00 and a day change percentage of -3.43%. It opened at Rs 112.05, moved up to Rs 122.45, and touched a low of Rs 111.05 during the market hours covered by this update. That range shows a session shaped by selling pressure after an early start, even though the current quote is still above the low point of the move.

For readers following HIMALAYA NUTRAVEDICS INDIA LIM Share Price Live, the important signal is that the stock is trading near a 52-week low rather than drifting comfortably above it. When a share price sits in that zone, the market usually watches whether the next move is a recovery attempt or another test of nearby support. Univest keeps the focus on the facts already visible in the price structure, which is why HIMALAYA NUTRAVEDICS INDIA LIM Share Price Today remains a stock news event for both short-term traders and long-term trackers.

The latest move also keeps HIMALAYA NUTRAVEDICS INDIA LIM Share Price on watch in broader Stock Market Today conversations, especially among stocks in news and stocks at 52 week low. The Indian stock market often gives more attention to small-cap healthcare names when they approach visible support levels. For now, the verified HIMALAYA NUTRAVEDICS INDIA LIM Share Price update shows a decline without a confirmed catalyst, which is exactly the kind of setup Univest tracks carefully.

HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 102.73 crore
P/E Ratio	13.9x
P/B Ratio	2.4x
ROE	50.56%
ROCE	42.64%
EPS	Rs 8.39
Book Value Per Share	Rs 48.69
Dividend Yield	0%

HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) fundamental metrics show P/E 13.9x, P/B 2.4x, ROE 50.56%, ROCE 42.64%. These figures provide context only and are not a buy or sell signal.

HIMALAYA NUTRAVEDICS INDIA LIM has a market capitalisation of Rs 102.73 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 13.9x, P/B at 2.4x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 50.56% and ROCE of 42.64%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 8.39, book value per share of Rs 48.69, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 27.12x, median ROE of 11.22%, median ROCE of 13.1%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	13.9x
Benchmark Median P/E	27.12x
Benchmark Average P/E	39.16x
Benchmark P/E Range	0x to 679.32x
Company P/B Ratio	2.4x
Benchmark Median P/B	2.8x
Company ROE	50.56%
Benchmark Median ROE	11.22%
Company ROCE	42.64%
Benchmark Median ROCE	13.1%
Company Market Capitalisation	Rs 102.73 crore
Benchmark Median Market Cap	Rs 734.46 crore

HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) has a P/E ratio of 13.9x, which is below the benchmark median of 27.12x, a difference of -48.75%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) has a ROE of 50.56%, which is above the benchmark median of 11.22%, a difference of +350.62%. HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) has a ROCE of 42.64%, which is above the benchmark median of 13.1%, a difference of +225.5%.

Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Asston Pharmaceuticals Ltd.	APL	103.49	26.78	1.57	50.56	42.64
Sotac Pharmaceuticals Ltd.	SOTAC	99.51	17.25	1.79	18.83	16.4
Tyche Industries Ltd.	TYCHE	106.81	23.97	0.76	9.42	12.69
Makers Laboratories Ltd.	MAKERSL	107.15	31.33	1.38	10.96	15.83
Pharmaids Pharmaceuticals Ltd.	PHARMAID	108.66	0	2.19	-21.64	-15.67

HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) has a P/E ratio of 13.9x compared with the displayed peer median of 23.97x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 50.56% compares with a peer median of 10.96% across the companies shown in the table. ROCE stood at 42.64% versus the displayed peer median of 15.83%, providing a capital-efficiency comparison. HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) has a market capitalisation of Rs 102.73 crore. Among the 5 peers shown, 4 have a larger market capitalisation.

Why Investors Are Watching HIMALAYA NUTRAVEDICS INDIA LIM

• HIMALAYA NUTRAVEDICS INDIA LIM Share Price is trading near its 52-week low, which keeps support levels in focus.
• The latest HIMALAYA NUTRAVEDICS INDIA LIM Share Price Today move shows weakness, but the price range remains measurable and clear.
• HIMALAYA NUTRAVEDICS INDIA LIM Fundamental Analysis shows P/E of 13.9 and P/B of 2.4, both useful for valuation context.
• ROE of 50.56% and ROCE of 42.64% keep HIMALAYA NUTRAVEDICS INDIA LIM Stock Analysis relevant for quality comparison.
• In sector context, HIMALAYA NUTRAVEDICS INDIA LIM Share Price remains below industry median valuation on P/E.

About HIMALAYA NUTRAVEDICS INDIA LIM

HIMALAYA NUTRAVEDICS INDIA LIM is part of the Healthcare sector and the Pharmaceuticals & Drugs industry. The available market context places it among smaller listed names, with a market cap of Rs 102.73 Cr. That positioning matters because HIMALAYA NUTRAVEDICS INDIA LIM Share Price can react more sharply to market sentiment than larger healthcare companies.

The supplied company context identifies the sector and industry, but not a detailed product mix. Even so, the available financial profile suggests a company that is judged largely through earnings quality, asset value and return ratios. For readers following HIMALAYA NUTRAVEDICS INDIA LIM Stock Performance, the key takeaway is that the share price event is occurring in a small-cap healthcare setup with clear valuation and profitability markers. Univest uses that company context to separate a plain price move from a broader stock news picture.

Track HIMALAYA NUTRAVEDICS INDIA LIM Share Price on Univest

Use HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.

Investors can track HIMALAYA NUTRAVEDICS INDIA LIM Share Price on Univest for live price updates, market cap, valuation ratios, shareholding pattern, 52-week levels, sector comparison and company-level stock news. Univest also helps readers follow HIMALAYA NUTRAVEDICS INDIA LIM Share Price Today alongside technical indicators when available, so the same page can support both quick checks and deeper stock analysis.

For anyone watching HIMALAYA NUTRAVEDICS INDIA LIM Latest News, the useful habit is to compare price action with fundamentals rather than reading the move in isolation. Univest stock pages are built for that type of monitoring, especially when a name like HIMALAYA NUTRAVEDICS INDIA LIM Share Price is trading close to a yearly low and entering the market news radar.

Frequently Asked Questions

Why is HIMALAYA NUTRAVEDICS INDIA LIM Share Price falling today?

Ans. The latest Univest data shows HIMALAYA NUTRAVEDICS INDIA LIM Share Price down 3.43% to Rs 112.65 versus the previous close of Rs 116.65. The data confirms the price move, but it does not establish a company-specific catalyst.

Is HIMALAYA NUTRAVEDICS INDIA LIM Share Price near its 52-week low?

Ans. Yes, HIMALAYA NUTRAVEDICS INDIA LIM Share Price is trading near its 52-week low, which keeps support levels in focus. That makes the move relevant for stock analysis and for investors tracking yearly low setups.

What is HIMALAYA NUTRAVEDICS INDIA LIM Share Price Today?

Ans. HIMALAYA NUTRAVEDICS INDIA LIM Share Price Today is Rs 112.65. The stock opened at Rs 112.05, touched a high of Rs 122.45 and a low of Rs 111.05 during the market hours covered here.

What does HIMALAYA NUTRAVEDICS INDIA LIM Fundamental Analysis show?

Ans. HIMALAYA NUTRAVEDICS INDIA LIM Fundamental Analysis shows a P/E of 13.9, P/B of 2.4, ROE of 50.56%, ROCE of 42.64%, EPS of 8.39 and book value of Rs 48.69, which supports a detailed valuation read.

How does HIMALAYA NUTRAVEDICS INDIA LIM compare with peers?

Ans. In the latest Univest peer set, HIMALAYA NUTRAVEDICS INDIA LIM Share Price sits alongside small-cap pharmaceuticals names with similar market caps. Its P/E is below several peers, while ROE and ROCE are stronger than most of the listed comparables.

What is the market cap of HIMALAYA NUTRAVEDICS INDIA LIM?

Ans. HIMALAYA NUTRAVEDICS INDIA LIM Market Cap is Rs 102.73 Cr. That places it in the small-cap range within Healthcare and makes price action more sensitive to market news and share market today sentiment.

What do ROE and ROCE say about HIMALAYA NUTRAVEDICS INDIA LIM Share Price?

Ans. ROE of 50.56% and ROCE of 42.64% indicate strong returns on equity and capital employed. For HIMALAYA NUTRAVEDICS INDIA LIM Share Price, those numbers provide a meaningful profitability backdrop. The stock moved -3.43% during the session.

Should investors track HIMALAYA NUTRAVEDICS INDIA LIM Share Price on Univest?

Ans. Yes, Univest lets readers follow HIMALAYA NUTRAVEDICS INDIA LIM Share Price Today, valuation ratios, market cap, 52-week levels and sector context in one place, which helps when a stock is near a yearly low.